Symptoms of Lower Urinary Tract Dysfunction Protocol 2/Recall Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

515 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-05-26

Study Completion Date

2018-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to advance the understanding of people who experience urinary and bladder problems. The investigators are interested in learning about people's experiences with urinary symptoms and how these symptoms will be managed. The investigators want to understand the important differences among people and what factors affect urinary and bladder problems. After all of the information is collected, the investigators will have a better understanding of how to improve the care and treatment for people who have urinary and bladder problems.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Symptoms of Lower Urinary Tract Dysfunction Phenotyping Study

NCT02485808

Lower Urinary Tract Symptoms

COMPLETED

EHR-integrated rUTI Texting Platform

NCT06035601

Recurrent Urinary Tract Infection

COMPLETED NA

Diagnosis and Treatment of Urinary Tract Infection Using DNA Polymerase Chain Reaction Versus Urine Culture

NCT06808451

Urinary Tract Infections

RECRUITING NA

Preventing UTIs in Chronic Neurogenic Bladder Dysfunction (Mix Methods)

NCT02591901

UTI Neurogenic Bladder Antibiotic Resistance

COMPLETED PHASE2

Validation of Bladder Health Instrument for Evaluation in Women

NCT04016298

Lower Urinary Tract Symptoms

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This protocol is part of an overall effort to create a state-of-the-art resource for measuring patient-reported health for patients with lower urinary tract dysfunction (LUTD). The primary purpose of this resource, known as the LURN PRO Battery, is to comprehensively characterize the self-reported experiences of patients with LUTD for the purpose of enhancing efforts to characterize and explain important subtypes of patients with LUTD (phenotypes). Secondary purposes of the LURN PRO Battery, for which additional development work will be required, include developing better patient-reported endpoints for clinical trials, monitoring symptoms in the course of clinical care, and screening patients into important subgroups for purposes of tailored interventions.

Incorporating methods the investigators have used successfully in prior measure validation work, the investigators propose to conduct a diary study in which patients record their symptoms at various time points - at the end of each day, or across multiple days. The investigators also ask them to complete self-report measures with different recall periods (i.e., 3-day, 7-day, and 30-day recall), and will determine how well each of these correspond to daily experiences recorded in more frequent assessments (i.e., end-of-day and 3-day patient bladder diaries). These data will help LURN investigators to determine the most appropriate reporting period for specific symptoms. This study can also help to identify causes of differences that exist between shorter and longer recall periods.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lower Urinary Tract Symptoms

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. age 18 or older,
2. willing and able to give informed consent,
3. able to speak, read, and understand English,
4. able to reliably complete self-reported questionnaires online at specified times (i.e., may exclude those who do not keep a regular schedule of sleeping during night hours), and
5. experienced at least moderate severity and bother from at least 1 of the 7 targeted symptoms in the past 2 weeks and in the past 3 months

Exclusion Criteria

1. dementia or other cognitive impairment that would interfere with study participation,
2. known pregnancy or delivery within past 6 months (women only)
3. planned change in medications to treat LUTS in the middle of the study time frame,
4. receiving active treatment for any malignancy (including maintenance medications),
5. received surgery with general or spinal/epidural anesthesia in the past 3 months or planned surgery during the study time frame
6. lower urinary tract instrumentation (e.g. self-catheterization or cystoscopy) in past 3 months or planned during the study time frame and
7. prostate biopsy in the past 3 months or planned during the study time frame

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No